Microbot Medical expands U.S. operations to prep for first in-human clinical study

-
Microbot Medical's LIBERTY system.

Microbot Medical’s LIBERTY system is a single-use endovascular robotic surgical system. | Source: Microbot Medical

Microbot Medical Inc., the developer of the LIBERTY Endovascular Robotic Surgical System, is building on the momentum from the positive results of its good laboratory practices, or GLP, pre-clinical study. The company is adding a clinical research associate to support its pending investigational device exemption, or IDE, submission to commence its first-in-human clinical trial. 

The clinical research associate (CRA) will join the Braintree Mass.-based company‘s established clinical team in the U.S. The team is led by Dr. Juan Diaz-Cartelle, chief medical officer of Microbot Medical. 

“Following the successful completion of our pivotal GLP pre-clinical trial, and as we are in the final stage of submitting our IDE, having an in-house CRA is a key piece for establishing the right infrastructure for clinical trial execution” said Diaz-Cartelle in a release.

SITE AD for the 2024 Robotics Summit registration.Learn from Agility Robotics, Amazon, Disney, Teradyne and many more.

Microbot Medical aims to improve endovascular surgeries 

Microbot Medical’s LIBERTY system aims to improve the use of surgical robotics in endovascular procedures. The system eliminates the need for large, cumbersome, and expensive capital equipment, according to the company. It can also reduce radiation exposure and physician strain. 

In December 2023, Microbot Medical completed a pre-clinical study of its LIBERTY system. The pre-clinical study is a necessary step toward Microbot Medical’s IDE submission to the U.S. Food and Drug Administration (FDA). During the study, three interventional radiologists used LIBERTY to perform a total of 96 robotic navigations. 

The radiologists used LIBERTY to examine and evaluate target vessels with surrounding tissue microscopically after subjecting them to procedures using a range of commercially available intravascular catheterization devices. All of these devices were controlled and manipulated with Microbot Medical’s system. 

LIBERTY is a single-use endovascular system. No dedicated infrastructure is required to use the system. This can lower barriers to obtaining and using the system, making the technology available to more healthcare providers, claimed Microbot Medical. 

Microbot teams up with Corewell Health

Microbot Medical is collaborating with Corewell Health for a multi-phase project to enable telerobotics between remote centers. The agreement also includes the mutual evaluation of the LIBERTY system for remote procedures. 

Corewell Health is a not-for-profit health system with more than 60,000 employees, including over 11,500 physicians and advanced practice providers, and more than 15,000 nurses. It said it provides care and services in 21 hospitals, over 300 outpatient locations, and several post-acute facilities.

Microbot Medical said it offers micro-robotic technologies to improve clinical outcomes for patients and increase accessibility through the natural and artificial lumens, or tubular structures, within the human body. 

The post Microbot Medical expands U.S. operations to prep for first in-human clinical study appeared first on The Robot Report.



from The Robot Report - Robotics News, Analysis & Research https://ift.tt/DTYxEyz
via artificialconference

Comments

Post a Comment

Popular posts from this blog

Chipotle testing avocado processing robot in test kitchen

-
Image
Chipotle Mexican Grill announced Autocado, an avocado processing cobotic prototype that cuts, cores, and peels avocados before they are hand mashed to create the restaurant’s famous guacamole. The prototype, developed in collaboration with Vebu , is currently being tested at the Chipotle Cultivate Center in Irvine , California.  How Autocado works  A team member loads Autocado with a full case of ripe avocados and selects the size setting. Autocado can hold up to 25 lbs. of avocados at once. One at a time, avocados are vertically oriented, then transferred to the processing device. The avocados are sliced in half. Their cores and skin are automatically removed, and the waste is discarded.  The fruit is safely collected in a stainless-steel bowl at the bottom of the device.  A team member removes the bowl of avocado fruit and moves it to the counter where they add additional ingredients and hand mash the avocados to make Chipotle’s signature guacamole.  How the Autocado idea s
Read more

Inside Comaus testing of Intrinsic Flowstate

-
Image
Intrinsic tested its latest platform and Flowstate with Comau , an Italian-based robot manufacturer and global systems integrator. Comau has been working with Intrinsic for several years now to validate Intrinsic’s platform technology and developer product, Flowstate, through real-world use cases.  Flowstate, announced earlier this year in May , is a robotic software development platform. It’s Intrinsic’s first developer product built on the Intrinsic platform. Comau was also introduced as the company’s first industry partner in May.  The Intrinsic Flowstate software  adds a layer of abstraction to traditional robotic software tools with the goal of reducing the development skillset required while making it easier than ever before to program a robot in simulation. “Partnering with Comau over the years has brought our team a tremendous amount of expertise, knowledge, and real-world use cases to focus our efforts on. We’re excited for what’s next and what it will mean to the solutio
Read more

ABB launches Flexley mobile robots, completing rebranding of ASTI AMRs

-
Image
Rebranded ABB Flexley autonomous mobile robots (AMRs) completes the integration of ASTI into ABB Robotics business. | Credit: ABB ABB launched its first range of rebranded Autonomous Mobile Robots (AMRs) following its acquisition of mobile robot leader ASTI Mobile Robotics in 2021 for $190M . ASTI Mobile Robotics’ solutions are now rebranded and integrated into ABB’s portfolio, grouped under the Flexley name, indicating the flexibility of operations that the AMRs offer. The first rebranded models to be released, Flexley Tug and Flexley Mover, cover applications including towing, trolley transportation up to 5,350 lbs (2000 kg), as well as lifting and transporting racks, containers and pallets of 4,000 lbs (1,500 kg). The ABB Flexley Mover (l) and ABB Flexley Tug (r) become the first rebranded ABB AMRs to be released. | Credit: ABB ABB joins OMRON corporation as the second automation solutions company to offer a complete lineup of autonomous mobile robots (AMRs), industrial robo
Read more